论文部分内容阅读
目的:研究分析急性出血性胃炎采用奥美拉唑联合硫糖铝治疗效果。方法:选取我院在2010年3月至2012年2月收治的84例急性出血性胃炎患者的临床资料进行研究分析,并随机将其分为治疗组(42例)和对照组(42例),对比两组患者临床治疗效果。结果:治疗组患者临床治疗总有效率为95.24%,对照组患者临床治疗总有效率为78.57%,对比两组患者临床治疗效果,治疗组患者临床治疗总有效率显著优于对照组患者的,有统计学意义(P<0.05);对比两组患者住院时间及出现复发率,治疗组患者住院时间及出现复发率同对照组患者之间存在显著差异性,有统计学意义(P<0.05)。结论:奥美拉唑联合硫糖铝在治疗急性出血性胃炎疾病临床上效果显著,可有效改善患者临床症状,值得推广应用。
Objective: To study the effect of omeprazole and sucralfate in the treatment of acute hemorrhagic gastritis. Methods: The clinical data of 84 patients with acute hemorrhagic gastritis treated in our hospital from March 2010 to February 2012 were analyzed and divided into treatment group (42 cases) and control group (42 cases) , Compared the clinical treatment effect of two groups of patients. Results: The total effective rate of clinical treatment was 95.24% in the treatment group and 78.57% in the control group. Compared with the clinical effect of the two groups, the total effective rate of clinical treatment in the treatment group was significantly better than that of the control group. There was significant difference between the two groups (P <0.05). Compared with the control group, the length of hospital stay and the recurrence rate of the two groups were significantly different (P <0.05) . Conclusion: The combination of omeprazole and sucralfate in the treatment of acute hemorrhagic gastritis is clinically effective, which can effectively improve the clinical symptoms of patients and is worth popularizing.